Back
Iterum Therapeutics PLC 10K Form
Sell
23
ITRM
Iterum Therapeutics PLC
Last Price:
$1.00
Seasonality Move:
-34.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-11-16 | 10Q | ITRM/Iterum Therapeutics PLC Quarterly |
| 2020-08-06 | 10K | ITRM/Iterum Therapeutics PLC Annual |
| 2020-08-06 | 10Q | ITRM/Iterum Therapeutics PLC Quarterly |
| 2020-05-14 | 10Q | ITRM/Iterum Therapeutics PLC Quarterly |
| 2020-03-12 | 10K | ITRM/Iterum Therapeutics PLC Annual |
| 2019-11-12 | 10Q | ITRM/Iterum Therapeutics PLC Quarterly |
Receive ITRM News And Ratings
See the #1 stock for the next 7 days that we like better than ITRM
ITRM Financial Statistics
Sales & Book Value
| Annual Sales: | $37K |
|---|---|
| Cash Flow: | $-3.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.07 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.96660 |
|---|---|
| Net Income (TTM): | $-22.6M |
| Gross Margin: | $-254K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Iterum Therapeutics PLC Earnings Forecast
Key Iterum Therapeutics PLC Financial Ratios
-
The Selling, General & Administrative Expenses for ITRM have been equal to 30,497.30% of Gross Profit Margin.
-
Per Share Earnings over the last 9 years have been positive in 6 years.
Iterum Therapeutics PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ITRM |
| CUSIP: | G6333L |
| Website: | iterumtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ITRM Technical Analysis vs Fundamental Analysis
Sell
23
Iterum Therapeutics PLC (ITRM)
is a Sell
Is Iterum Therapeutics PLC a Buy or a Sell?
-
Iterum Therapeutics PLC stock is rated a SellThe current Iterum Therapeutics PLC [ITRM] share price is $0.99. The Score for ITRM is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.